The Newborn Screening (NBS) Market is projected to reach $2.07 billion by 2029, at a CAGR of 8.9% from 2022 to 2029. Newborn screening is performed for the early identification of the conditions that can affect the child’s survival or long-term health. The screening technology specifies a series of essential tests for early detection, health management, timely diagnosis, management and prevention of disabilities in newborns. These tests are performed in a short period of time after the child is born to detect metabolic, genetic and developmental disorders in children. The screening is usually done by collecting blood samples from newborns’ heels for different endocrine, metabolic and genetic disorders. The newborns are also tested for critical congenital heart disease (CCHDs) and hearing defects before the child is discharged from the birthing center or hospital.
The increasing neonatal population, rising government support for newborn screening, high birth rate, and rising incidences of neonatal disorders are the factors driving the growth of the newborn screening market. Additionally, the growing awareness and implementation of screening programs in emerging markets such as India, China, and Brazil are likely to boost the market over the forecast period. However, the lack of professionals with expertise in childcare and instances of false-positive results are some of the challenging factors for the market.
The Impact of COVID-19 on the Newborn Screening Market
The outbreak of COVID-19 pandemic heavily burdened the healthcare systems across the world. A significantly high influx of patients in the hospitals resulted in the prioritization of healthcare resources towards the most affected COVID-19 patients. Since COVID-19 testing is often performed within the same agency as the laboratory component of NBS, there were documented shortages of supplies, equipment and personnel during the pandemic.
Some of the major obstacles reported during the pandemic for newborn screening were lack of staff, lack of effective communication with the parents, and hospital capacity issues related to COVID-19 patient activity. There were also delays in test results and a shortage of new NBS kits and other laboratory equipment. Additionally, owing to the severe lockdowns and restrictions, there were also supply chain issues for the NBS products. These factors had a negative impact on the newborn screening market to a certain extent.
Click here to: Get Free Sample Copy of this report
Increasing Awareness of Newborn Screening is Driving the Market Growth
Newborn screening has been recognized and initiated by governments of various countries worldwide due high prevalence of genetic and/or metabolic conditions in newborns. Owing to the increasing importance of newborn screening in identifying infants at risk of diseases and aiding in timely diagnosis and management, various countries have made newborn screening tests compulsory. For instance, the U.S. government has made newborn screening compulsory soon after birth. Since the 1960s, NBS programs have become the most effective health programs in the U.S., which tests for 31 out of 35 core conditions recommended by the Uniform Screening Panel (RUSP). It is estimated that around 4 million babies are screened annually for serious disorders present at birth in the U.S. (Source: National Organization for Rare Disorders).
Collaborations are also being done between public and private organizations for newborn screening. For instance, in 2021, PerkinElmer, Inc. (U.S.) collaborated with International Society for Neonatal Screening (ISNS) to bring attention to India’s rare diseases policy 2021 and discuss strategies to improve newborn and maternal health. The Government of India and PerkinElmer(U.S.) had also collaborated for genetic testing and newborn screening training. Additionally, in 2018 government of Ghana collaborated with Sickle Cell Foundation of Ghana and U.S. Centers for Disease Control and Prevention (CDC) to provide technical assistance regarding post and pre-term screening activities, including genetic counseling to health workers and parents. Thus, the growing importance of newborn screening and key developments in the newborn screening market are collectively driving the market.
High Prevalence Rate of Congenital Anomalies among Newborns is Driving the Market
Newborn screening is crucial for the early detection, diagnosis and intervention of a condition or disorder. Each year, around 7.9 million infants are born with serious congenital anomalies globally, which amounts to around 6% of global births. (Source: Nature Journal). According to WHO, it is estimated that 9 of 10 children born with a serious congenital anomaly are in low- and middle-income countries. Some of the most common severe congenital anomalies are heart defects, neural tube defects and down syndrome. Congenital heart disease is estimated to affect approximately 0.8% to 1.2% of newborns globally (Source: Medicine Journal, 2020). These congenital disorders are a major cause of mortality among infants. According to WHO , around 240,000 newborns die worldwide within 28 days of birth every year due to congenital anomalies.
The high prevalence rate of various congenital disorders and the growing awareness among parents regarding newborn screening are expected to drive the growth of this market.
Key Findings in the Newborn Screening Market Study:
Based on Product, in 2022, the Consumables Segment is Expected to Account for the Largest Share of the Market
Based on product, the newborn screening market is segmented into consumables and instruments. In 2022, the consumables segment is expected to account for the largest share of the market. The main factors contributing to the large market share of this segment are repeat purchases of consumables for screening of newborns, availability of advanced kits, and high awareness about newborn screening in developed countries.
Based on Technology, in 2022, the Immunoassays & Enzymatic Assays Segment is Expected to Account for the Largest Share of the Market
Based on technology, the newborn screening market is segmented into immune assays & enzymatic assays, tandem mass spectrometry, molecular assays, hearing screening technologies, pulse oximetry, and other technologies. In 2022, the immune assays & enzymatic assays segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the advantages of immune assays & enzymatic assays, such as cost-effectiveness, high applicability, short turnaround time, and rapid technological advancements.
Based on Application, in 2022, the Inherited Disorders Segment is Expected to Account for the Largest Share of the Market
Based on the application, the newborn screening market is segmented into congenital heart disease, inherited disorders, infectious diseases, hearing disorders, and other applications. In 2022, the inherited disorders segment is expected to account for the largest share of the market. The large market share of this segment is due to the high prevalence of inherited disorders among newborns, variations or mutations in the genes, inherited gene defects, and abnormality in genetic composition.
Based on End User, in 2022, the Hospitals Segment is Expected to Account for the Largest Share of the Market
Based on end user the newborn screening market is segmented into hospitals, diagnostic laboratories, maternity & specialty clinics, and other end users. In 2022, the hospitals segment is expected to account for the largest share of the market. The high preference of hospitals for childbirth delivery, better infrastructure, utilization of advanced techniques in the hospitals, and the availability of skilled professionals are some factors contributing to the large market share of this segment.
Asia-Pacific: Fastest Growing Regional Market
Asia-Pacific is slated to register the highest CAGR in the newborn screening market during the forecast period. The high market growth in Asia-Pacific is attributed to high fertility rates in the region, improving healthcare infrastructure, and increasing disposable income. In 2020, the fertility rates in India and China were 2.2 and 1.8, respectively (Source: World Bank). Additionally, government initiatives and growing awareness in the region about newborn screening and its advantages and rising healthcare expenditure are likely to boost the newborn screening market in Asia-Pacific.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years. The key players profiled in the global newborn screening market are Thermo Fisher Scientific Inc. (U.S.), General Electric Company (U.S.), Natus Medical Incorporated (U.S.), PerkinElmer, Inc. (U.S.), Medtronic plc (Ireland), Trivitron Healthcare (India), Bio-Rad Laboratories, Inc. (U.S.), Demant A/S (Denmark), Baebies, Inc. (U.S.), and ZenTech (Belgium).
Scope of the Report:
Newborn Screening Market, by Product
Newborn Screening Market, by Technology
Newborn Screening Market, by Application
Newborn Screening Market, by End User
Newborn Screening Market, by Geography
Key questions answered in the report:
This study offers a detailed assessment of the newborn screening market, including the market size & forecast for various segmentation like product, application, technology, and end user. The newborn screening market studied in this report also involves the value analysis of various segments of newborn screening at regional and country levels.
The global newborn screening market is projected to reach $2.07 billion by 2029, at a CAGR of 8.9% during the forecast period.
The newborn screening market is segmented into consumables and instruments. In 2022, the consumables segment is expected to account for the largest share of the market.
In 2022, the inherited disorders segment is expected to account for the largest share of the market.
Factors such as increasing government support/initiatives promoting newborn screening, high birth rate, and rising incidences of neonatal disorders are driving the newborn screening market. Additionally, growing awareness and implementation of screening programs in emerging markets such as India, China, and Brazil are likely to boost the market over the forecast period.
The key players operating in the global newborn screening market are Thermo Fisher Scientific Inc. (U.S.), General Electric Company (U.S.), Natus Medical Incorporated (U.S.), PerkinElmer, Inc. (U.S.), Medtronic plc (Ireland), Trivitron Healthcare (India), Bio-Rad Laboratories, Inc. (U.S.), Demant A/S (Denmark), Baebies, Inc. (U.S.), and ZenTech (Belgium).
Growing adoption of newborn screening in emerging economies such as China, Brazil India, and factors such as high fertility rates in developing countries, rising healthcare expenditure, and increasing focus of governments of different countries to adopt newborn screening are the major factors expected to provide growth opportunities for players operating in this market.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Neonatal Population
4.2.2. Awareness of Non-invasive and Minimally Newborn Screening Procedures
4.2.3. Rising Prevalence of Congenital Heart Diseases and Genetic Disorders
4.3. Restraints
4.3.1. Limited Availability of Professionals
4.4. Opportunities
4.4.1. Emerging Economies
4.5. Challenges
4.5.1. Ethical Concerns of Newborn Screening
4.6. Impact Assessment of COVID-19
5. Newborn Screening Market, by Product
5.1. Introduction
5.2. Consumables
5.2.1. Assays, Kits, and Reagents
5.2.2. Other Consumables
5.3. Instruments
6. Newborn Screening Market, by Technology
6.1. Introduction
6.2. Hearing Screening Technologies
6.3. Tandem Mass Spectrometry
6.4. Pulse Oximetry
6.5. Immune Assays & Enzymatic Assays
6.6. Molecular Assays
6.7. Other Technologies
7. Newborn Screening Market, by Application
7.1. Introduction
7.2. Congenital Heart Disease
7.3. Inherited Disorders
7.3.1. Metabolic Disorders
7.3.2. Hemoglobin Disorders
7.3.3. Endocrine Disorders
7.3.4. Other Inherited Disorders
7.4. Infectious Diseases
7.5. Hearing Disorders
7.6. Other Applications
8. Newborn Screening Market, by End User
8.1. Hospitals
8.2. Maternity & Specialty Clinics
8.3. Diagnostic Laboratories
8.4. Other End Users
9. Newborn Screening Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (RoLATM)
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2021)
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. GE Healthcare
11.3. Natus Medical Incorporated
11.4. PerkinElmer, Inc.
11.5. Medtronic plc
11.6. Trivitron Healthcare
11.7. Bio-Rad Laboratories, Inc.
11.8. Demant A/S
11.9. Baebies, Inc
11.10. ZenTech
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global Newborn Screening Market: Impact Analysis (2022–2029)
Table 2 Global Newborn Screening Market Restraints: Impact Analysis (2022–2029)
Table 3 Global Newborn Screening Market Size, by Product 2020–2029 (USD Million)
Table 4 Global Newborn Screening Market Size for Consumables, 2020–2029 (USD Million)
Table 5 Global Newborn Screening Consumables Market Size for Assay Kits & Reagents, by Country/Region, 2020–2029 (USD Million)
Table 6 Global Newborn Screening Consumables Market Size for Other Consumables, by Country/Region, 2020–2029 (USD Million)
Table 7 Global Newborn Screening Market Size for Instruments, by Country/Region, 2020–2029 (USD Million)
Table 8 Global Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 9 Global Newborn Screening Market Size for Immune Assays & Enzymatic Assays, by Country/Region, 2020–2029 (USD Million)
Table 10 Global Newborn Screening Market Size for Tandem Mass Spectrometry, by Country/Region, 2020–2029 (USD Million)
Table 11 Global Newborn Screening Market Size for Molecular Assays by Country/Region, 2020–2029 (USD Million)
Table 12 Global Newborn Screening Market Size for Hearing Screening Technologies by Country/Region, 2020–2029 (USD Million)
Table 13 Global Newborn Screening Market Size for Pulse Oximetry by Country/Region, 2020–2029 (USD Million)
Table 14 Global Newborn Screening Market Size for Other Technologies, by Country/Region, 2020–2029 (USD Million)
Table 15 Global Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 16 Global Newborn Screening Market Size for Congenital Heart Diseases, by Country/Region, 2020–2029 (USD Million)
Table 17 Global Newborn Screening Market Size for Inherited disorders, by Country/Region, 2020–2029 (USD Million)
Table 18 Global Newborn Screening Market Size for Inherited disorders, 2020–2029 (USD Million).
Table 19 Global Newborn Screening Market Size for Inherited Metabolic Disorders, by Country/Region, 2020–2029 (USD Million)
Table 20 Global Newborn Screening Market Size for Inherited Endocrine Disorders, by Country/Region, 2020–2029 (USD Million)
Table 21 Global Newborn Screening Market Size for Hemoglobin Disorders, by Country/Region, 2020–2029 (USD Million)
Table 22 Global Newborn Screening Market Size for Other Inherited Disorders, by Country/Region, 2020–2029 (USD Million)
Table 23 Global Newborn Screening Market Size for Infectious Diseases, by Country/Region, 2020–2029 (USD Million)
Table 24 Global Newborn Screening Market Size for Hearing Disorders, by Country/Region, 2020–2029 (USD Million)
Table 25 Global Newborn Screening Market Size for Other Applications, by Country/Region, 2020–2029 (USD Million)
Table 26 Global Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 27 Global Newborn Screening Market Size for Hospitals, 2020–2029 (USD Million)
Table 28 Global Newborn Screening Market Size for Diagnostic Laboratories, 2020–2029 (USD Million)
Table 29 Global Newborn Screening Market Size for Maternity & Specialty Clinics, 2020–2029 (USD Million)
Table 30 Global Newborn Screening Market Size for Other End Users, 2020–2029 (USD Million)
Table 31 Global Newborn Screening Market Size by Country/Region, 2020–2029 (USD Million)
Table 32 North America: Newborn Screening Market Size, by Country, 2020–2029 (USD Million)
Table 33 North America: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 34 North America: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 35 North America: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 36 North America: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 37 North America: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 38 North America: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 39 U.S.: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 40 U.S.: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 41 U.S.: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 42 U.S.: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 43 U.S.: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 44 U.S.: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 45 Canada: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 46 Canada: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 47 Canada: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 48 Canada: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 49 Canada: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 50 Canada: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 51 Europe: Newborn Screening Market Size, by Country/Region, 2020–2029 (USD Million)
Table 52 Europe: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 53 Europe: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 54 Europe: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 55 Europe: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 56 Europe: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 57 Europe: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 58 U.K.: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 59 U.K.: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 60 U.K.: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 61 U.K.: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 62 U.K.: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 63 U.K.: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 64 Germany: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 65 Germany: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 66 Germany: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 67 Germany: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 68 Germany: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 69 Germany: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 70 France: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 71 France: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 72 France: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 73 France: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 74 France: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 75 France: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 76 Spain: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 77 Spain: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 78 Spain: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 79 Spain: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 80 Spain: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 81 Spain: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 82 Italy: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 83 Italy: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 84 Italy: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 85 Italy: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 86 Italy: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 87 Italy: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 88 Rest of Europe: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 89 Rest of Europe: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 90 Rest of Europe: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 91 Rest of Europe: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 92 Rest of Europe: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 93 Rest of Europe: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 94 Asia-Pacific: Newborn Screening Market Size, by Country/Region, 2020–2029 (USD Million)
Table 95 Asia-Pacific: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 96 Asia-Pacific: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 97 Asia-Pacific: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 98 Asia-Pacific: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 99 Asia-Pacific: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 100 Asia-Pacific: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 101 China: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 102 China: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 103 China: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 104 China: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 105 China: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 106 China: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 107 Japan: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 108 Japan: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 109 Japan: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 110 Japan: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 111 Japan: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 112 Japan: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 113 India: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 114 India: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 115 India: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 116 India: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 117 India: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 118 India: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 119 Rest of Asia-Pacific: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 120 Rest of Asia-Pacific: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 121 Rest of Asia-Pacific: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 122 Rest of Asia-Pacific: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 123 Rest of Asia-Pacific: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 124 Rest of Asia-Pacific: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 125 Latin America: Newborn Screening Market Size, by Country/Region, 2020–2029 (USD Million)
Table 126 Latin America: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 127 Latin America: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 128 Latin America: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 129 Latin America: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 130 Latin America: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 131 Latin America: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 132 Brazil: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 133 Brazil: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 134 Brazil: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 135 Brazil: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 136 Brazil: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 137 Brazil: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 138 Mexico: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 139 Mexico: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 140 Mexico: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 141 Mexico: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 142 Mexico: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 143 Mexico: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 144 Rest of Latin America: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 145 Rest of Latin America: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 146 Rest of Latin America: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 147 Rest of Latin America: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 148 Rest of Latin America: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 149 Rest of Latin America: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 150 Middle East & Africa: Newborn Screening Market Size, by Product, 2020–2029 (USD Million)
Table 151 Middle East & Africa: Newborn Screening Consumables Market Size, by Type, 2020–2029 (USD Million)
Table 152 Middle East & Africa: Newborn Screening Market Size, by Technology, 2020–2029 (USD Million)
Table 153 Middle East & Africa: Newborn Screening Market Size, by Application, 2020–2029 (USD Million)
Table 154 Middle East & Africa: Newborn Screening Market Size for Inherited Disorders, by Type, 2020–2029 (USD Million)
Table 155 Middle East & Africa: Newborn Screening Market Size, by End User, 2020–2029 (USD Million)
Table 156 Recent Developments, by Company, (2020–2022)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Source
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Newborn Screening Market, by Product, 2022–2029 (USD Million)
Figure 8 Global Newborn Screening Market, by Technology, 2022–2029 (USD Million)
Figure 9 Global Newborn Screening Market, by Application, 2022–2029 (USD Million)
Figure 10 Global Newborn Screening Market, by End User, 2022–2029 (USD Million)
Figure 11 Global Newborn Screening Market, by Geography
Figure 12 Market Dynamics: Newborn Screening Market
Figure 13 Global Newborn Screening Market, by Product, 2022–2029 (USD Million)
Figure 14 Global Newborn Screening Market, by Technology, 2022–2029 (USD Million)
Figure 15 Global Newborn Screening Market, by Application, 2022–2029 (USD Million)
Figure 16 Global Newborn Screening Market, by End User, 2022–2029 (USD Million)
Figure 17 Global Newborn Screening Market, by Region, 2022–2029 (USD Million)
Figure 18 North America: Newborn Screening Market Snapshot
Figure 19 Europe: Newborn Screening Market Snapshot
Figure 20 Asia-Pacific: Newborn Screening Market Snapshot
Figure 21 Latin America: Newborn Screening Market Snapshot
Figure 22 Recent Developments, by Company, (2020–2022)
Figure 23 Global Newborn Screening Market Competitive Benchmarking, By Product
Figure 24 Global Newborn Screening Market Competitive Benchmarking, By Region
Figure 25 Thermo Fisher Scientific Inc: Financial Overview (2021)
Figure 26 GE Healthcare: Financial Overview (2021)
Figure 27 Natus Medical Incorporated: Financial Overview (2021)
Figure 28 PerkinElmer, Inc.: Financial Overview (2021)
Figure 29 Medtronic Plc.: Financial Overview (2021)
Figure 30 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 31 Demant A/S: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Oct-2017
Published Date: Feb-2018
Published Date: Apr-2023
Published Date: Apr-2017
